Patterson Intellectual Property Law

Our People

Back To People

Mark Kilgore, Ph.D.


Mark Kilgore, Ph.D. focuses on patent prosecution and intellectual property infringement litigation.  Dr. Kilgore provides prosecution services in the fields of biotechnology, pharmaceuticals, medical devices, and the mechanical arts.  Dr. Kilgore also provides freedom-to-operate and invalidity opinions to clients in the areas of biotechnology and the life sciences.  In addition to patent prosecution services, he has experience in traditional infringement cases and administrative reviews before the USPTO and provides counsel for trademark and copyright issues.

Dr. Kilgore attended Cumberland School of Law in Birmingham, Alabama where he graduated cum laude and was a research and writing editor for the American Journal of Trial Advocacy.  Before law school, he obtained his Ph.D. in Neurobiology from the University of Alabama at Birmingham (UAB).  His research focused on the molecular mechanisms of learning and memory in the lab of Dr. David Sweatt.


  • J.D., cum laude, Cumberland School of Law, 2016
  • Ph.D., Neurobiology, University of Alabama Birmingham, 2013
  • M.S., Microbiology, Auburn University, 2007
  • B.S., Microbiology, Auburn University, 2005

Bar Admissions

  • Georgia
  • Tennessee
  • Registered Patent Attorney (USPTO)

Professional Memberships

  • American Bar Association
  • American Intellectual Property Law Association
  • BIO Alabama
  • Society for Neuroscience


  • Mark Kilgore, Technological Innovation for Helmet Safety in Reducing Concussion Impact, Attorney at Law Magazine, Middle Tennessee Edition, Vol. 3, No.4, at 7
  • Mark A. Kilgore, United States v. Richardson: The Federal Circuit Split Over When Custody and Interrogation Requires a Miranda Warning Under the 5th Amendment, 38 AM. J. TRIAL ADVOC. 391 (2015)
  • Thesis, “The Role of Histone Deacetylase Inhibitors in Ameliorating Memory Dysfunction of Alzheimer’s Disease,” University of Alabama at Birmingham, 2013
  • “Inhibitors of Class I Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer’s Disease,” Neuropsychopharmacology (2010), 35:870-880
  • “Pharmacological Selectivity within Class I Histone Deacetylases Predicts Effects on Synaptic Function and Memory Rescue,” Neuropsychopharmacology (2015), 40(10):2307-2316
  • Form Over Function – The Growing Trend of Design Patent Protection, Mark A. Kilgore, William E. Sekyi, Association of Corporate Counsel Tennessee Focus, (Q3 2019)